Furthermore, analysis of immune-signature revealed that tumour environments of ARID1A-deficient tumours were infiltrated with specific subtypes of immune cells, such as subsets of CD4+, CD8+ T cells and NK cells, type 17 T-helper cells (Th17), and so on. The gene discussed is ARID1A; the disease is neoplasm.